Status:
COMPLETED
Valuation of Efficacy and Safety of Vitamin D3 Use in 80 Women Diagnosed With Fibromyalgia. Using FIQ Score and VAS.
Lead Sponsor:
Universidad Autonoma de Nuevo Leon
Conditions:
Fibromyalgia
D Vitamin Deficiency
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
Fibromyalgia is a disease that significantly decreases the quality of life of people who suffer from it, has great repercussions at the socio-economic level due to the incapacity it produces. It is ch...
Detailed Description
Fibromyalgia is a disease characterized mainly by generalized pain, with great repercussion in the patient's quality of life as well as in his work and social performance. There are different therapie...
Eligibility Criteria
Inclusion
- Female patients older than 18 years.
- Patients who agree to participate in the study.
- Those that meet the ACR 1990 and 2010 criteria for Fibromyalgia.
- No previous use of vitamin D.
- Patients diagnosed with primary or secondary fibromyalgia.
Exclusion
- Those subjects with previous use of vitamin D.
- Known subjects with renal, liver, calcium metabolism disorders, malabsorption disorders, known neoplasms.
- Subjects with serum calcium levels equal to or greater than 10.2 mg / dl.
Key Trial Info
Start Date :
May 31 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2017
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03369379
Start Date
May 31 2017
End Date
December 31 2017
Last Update
June 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidad Autónoma de Nuevo León
Monterrey, Nuevo León, Mexico, 66460